IBHS Releases Its Most Expansive Impact-Resistant Shingle Ratings to Date

Fourth edition captures record 24 products, offering the broadest look yet at IR shingle performance The Insurance Institute for Business & Home Safety (IBHS) today released the 2025 update to its Hail Impact-Resistant Shingle Ratings, reinforcing its commitment to improving asphalt shingle durability and reducing storm damage. Now in its fourth edition, this year researchers […]

Eloro Resources Further Expands Extent of Potential Starter Pit Zone, Intersecting 90 metres grading 61.05 g/t Silver and 0.20% Tin at its Iska Iska Project, Potosi Department, Southern Bolivia

(TSX:ELO),(OTC US:ELRRF),(Other OTC:ELRRF),(Boerse Frankfurt – Freiverkehr:P2QM), Highlights: The potential starter pit at the Santa Barbara zone continues to be open laterally and downdip with definition drilling continuing to return long and higher-grade intercepts. Additional infill and step-out drilling offers significant potential to further expand and upgrade the mineral resources for the planned PEA. DSB-92, a

Juno Announces $18 Million Fully Allocated Non-Brokered Private Placement with Participation from Northfield Capital and Strategic Investor

(TSX-V:NFDA),(TSX-V:NFD-A), Not for distribution to U.S. Newswire Services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) — Northfield Capital Corporation (TSX-V: NFD.A) (“Northfield“) and Juno Corp. (“Juno“) are pleased to announce that Juno will be undertaking

White Gold Corp. Welcomes Federal Nation-Building Investments and Support for Resource Development in Yukon

(TSX-V:WGO),(Boerse Frankfurt – Freiverkehr:29W),(OTC US:WHGOF),(Other OTC:WHGOF), TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) — White Gold Corp. (TSX.V: WGO, OTCQX: WHGOF, FRA: 29W) (the “Company”) welcomes the Government of Canada's announcement of the second tranche of nation-building projects under Budget 2025: Canada Strong. This new tranche in federal commitments across infrastructure, clean energy, and resource-corridor development

Mobix Labs Expands Into High-Growth AI Infrastructure With Strategic Investment in TalkingHeads Wireless

(NASDAQ:MOBX), IRVINE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (Nasdaq: MOBX), a high-performance fabless semiconductor and connectivity company, today announced it has taken a strategic minority stake in TalkingHeads Wireless (THW), an AI-powered wireless infrastructure innovator and Mobix Labs' development partner since November 2024. Terms of the investment were not disclosed. This

Aya Gold & Silver Unlocks Near-Term Value and Advances Environmental Remediation with Sale of Precious Metals from Legacy Boumadine Stockpile

(TSX:AYA),(OTC US:AYASF),(Other OTC:AYASF), MONTREAL, Nov. 19, 2025 (GLOBE NEWSWIRE) — Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce the start of commercial production from a historical flotation stockpile of precious metal rich pyrite concentrate, located within its Boumadine mining license. Recovering these metals will help reduce

Troilus Upsizes Debt Financing Mandate to US$1 Billion

(TSX:TLG),(OTC US:CHXMF),(Other OTC:CHXMF),(Boerse Frankfurt – Freiverkehr:CM5R), MONTREAL, Nov. 19, 2025 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQX: CHXMF; FRA: CM5R) (“Troilus” or the “Company”) is pleased to announce that it has increased its previously announced debt financing mandate from US$700 million to up to US$1 billion (see March 13, 2025, press release). The

SCYNEXIS Completes Transfer of BREXAFEMME(R) New Drug Application to GSK

(NasdaqGM:SCYX), GSK remains committed to the relaunch of BREXAFEMME, and following its relaunch, SCYNEXIS stands to receive up to $145.5 million in annual net sales milestones as well as royalties, net of payments to Merck, in the low to mid single digit range JERSEY CITY, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ:

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU(TM) in Wet Age-Related Macular Degeneration

(NasdaqGM:EYPT), – No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety signals, consistent with previous clinical trials for DURAVYU – – On track to report topline 56-week data for LUGANO in mid-2026 with LUCIA data to closely follow – WATERTOWN, Mass., Nov. 19,

Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference

(NASDAQ:AVIR), BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, together with other members of the Atea management

Scroll to Top